Skip to content

A Phase 1 Study of JNJ-87189401 Combined with JNJ-78278343 for Advanced Prostate Cancer

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504063-17-00
Acronym
87189401PCR1001
Enrollment
71
Registered
2024-02-23
Start date
2024-03-08
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Prostate Cancer

Interventions

None listed

Sponsors

Janssen - Cilag International
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Countries

France, Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026